1.OncoimmunologyTadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)."12-4777 was used in Flow cytometry/Cell sorting to evaluate biologic effects, safety and efficacy of palliative treatment with the PDE-5 inhibitor tadalafil in metastatic melanoma patients."AuthorsHassel JC,Jiang H,Bender C,Winkler J,Sevko A,Shevchenko I,Halama N,Dimitrakopoulou-Strauss A,Haefeli WE,Jäger D,Enk A,Utikal J,Umansky V2.Experimental hematology and oncologyChanges in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation withJAK2V617Fallelic burden.AuthorsKovacsovics-Bankowski M,Kelley TW,Efimova O,Kim SJ,Wilson A,Swierczek S,Prchal J3.Frontiers in immunologyATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells."12-4777 was used in Flow cytometry/Cell sorting to study the effect of ATP release in acute myeloid lymphoma on the generation of an immune suppressive microenvironment."AuthorsLecciso M,Ocadlikova D,Sangaletti S,Trabanelli S,De Marchi E,Orioli E,Pegoraro A,Portararo P,Jandus C,Bontadini A,Redavid A,Salvestrini V,Romero P,Colombo MP,Di Virgilio F,Cavo M,Adinolfi E,Curti A4.GutDifferential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo."12-4777 was used in Flow cytometry/Cell sorting to analyse the homing of effector and regulatory T-cells to the inflamed gut via α4β7 and GPR15."AuthorsFischer A,Zundler S,Atreya R,Rath T,Voskens C,Hirschmann S,López-Posadas R,Watson A,Becker C,Schuler G,Neufert C,Atreya I,Neurath MF5.Cancer researchThe CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells."12-4777 was used in Immunocytochemistry to investigate the CD4+ T-cell response of melanoma patients to a MAGE-A3 peptide vaccine."AuthorsFrançois V,Ottaviani S,Renkvist N,Stockis J,Schuler G,Thielemans K,Colau D,Marchand M,Boon T,Lucas S,van der Bruggen P |